· Agency action
United States v. Cerebral, Inc.
Federal Trade Commission, through the Department of Justice; U.S. District Court for the Southern District of Florida, No. 1:24-cv-21376-JLK
Primary source: FTC case page. Checked on November 10, 2026.
Telehealth company Cerebral agreed to a consent judgment barring it from using or disclosing consumers' personal and health information for most advertising, resolving charges that included sharing nearly 3.2 million consumers' data through tracking tools.
What happened
The complaint described Cerebral as a seller of subscription telehealth services, including mental health treatment, medication management and, in 2021 and 2022, treatment for substance use disorders. On April 12, 2024, the United States sued Cerebral and its former chief executive in the Southern District of Florida on a referral from the Federal Trade Commission. The claims arose under the FTC Act, the Opioid Addiction Recovery Fraud Prevention Act and the Restore Online Shoppers' Confidence Act.
The complaint alleged that from 2019 to 2023 Cerebral used or integrated third-party tracking tools, including pixels, on its websites and apps. It alleged that the tools sent patients' contact information, persistent identifiers, activity on the sites and mental health questionnaire answers to twenty or more third parties for marketing, including LinkedIn, Snapchat and TikTok. It also alleged that in March 2023 Cerebral told HHS its use of tracking tools was a breach of unsecured health information protected under HIPAA that affected nearly 3.2 million consumers.
The complaint also alleged that Cerebral promised confidential care and said it would not use protected health information for marketing without consent. According to the complaint, its privacy policy described pixel tags as collecting non-personal or aggregate information and first mentioned the Facebook Pixel in December 2020, five pages into a fifteen-page policy. Other counts charged data security failures and cancellation practices.
Cerebral stipulated to an order resolving the case against it without admitting or denying the allegations, and the court entered a consent judgment on June 17, 2024. The judgment did not resolve the claims against the former chief executive or the other defendants added by an amended complaint on May 31, 2024. This page describes the order's terms from the stipulated order filed with the court on April 15, 2024 (ECF No. 6).
What the agency did
On June 17, 2024, the court entered a consent judgment for the United States against Cerebral, Inc., resolving the claims against that company. (ECF No. 33 (docket entry, June 17, 2024))
CONSENT JUDGMENT is entered in favor of Plaintiff United States of America against Defendant Cerebral, Inc.
ECF No. 33 (docket text) The stipulated order permanently bars Cerebral from using or disclosing Covered Information for advertising or marketing purposes or for any third party's purposes. The only carve-out covers limited visitor data: persistent identifiers, email addresses and pages viewed before login that disclose no individually identifiable health information. That data may be used for analytics, advertising measurement or communications the consumer requested, but not for targeted advertising or to build a profile. (ECF No. 6 at 9, 13-14)
permanently restrained and enjoined from using or disclosing to any third party Covered Information for Defined Advertising Purposes or for any third party’s purposes.
ECF No. 6 at 14 Cerebral must obtain affirmative express consent before disclosing Covered Information to any outside party, meaning anyone other than Cerebral, a service provider that handles the data only to perform services for Cerebral, and a few others the order lists, such as its own therapists and prescribers. That consent must be a freely given, specific, informed and unambiguous indication of agreement, such as a clear affirmative action, following a clear and conspicuous disclosure of what is collected, why, and who receives it. The disclosure must be separate from any privacy policy or terms, and consent cannot be inferred from hovering over, muting, pausing or closing content. (ECF No. 6 at 3-4, 9-10, 14-15)
The Clear and Conspicuous disclosure must be separate from any “privacy policy,” “notice of privacy practices,” “terms of service,” “terms of use,” or other similar document.
ECF No. 6 at 3 The order's definition of Covered Information includes static IP addresses, user IDs, mobile advertising IDs and other persistent identifiers, and account credentials even when hashed. It also includes Treatment Information, which covers a consumer's use of, account with, or questionnaire answers about Cerebral's services and information inferred from them. (ECF No. 6 at 6-7, 13)
information concerning the consumer’s use of, creation of an account associated with, or response to a question, questionnaire, or assessment related to, a service or product offered by Defendant
ECF No. 6 at 13 Cerebral had to identify every third party that received Covered Information in any form, including hashed or encrypted form, send each one the complaint and order, and instruct it to delete the data. It also had to delete data it held that was not collected or used for treatment, payment or health care operations, unless consumers consented to its retention. And it had to post a notice on its website and send the notice to consumers who gave it information from October 2019 to March 1, 2023. (ECF No. 6 at 33-37)
Identify all third parties that received Covered Information from Defendant in any form, including in hashed or encrypted form;
ECF No. 6 at 36 The order enters a $5,087,252.89 monetary judgment and a $10 million civil penalty judgment that is suspended once Cerebral pays $2 million, with the suspension to be lifted if the court finds that Cerebral's sworn financial statements were materially false or incomplete. (ECF No. 6 at 43-45)
Upon such payment, the remainder of the civil penalty judgment is suspended
ECF No. 6 at 44 Cerebral neither admitted nor denied the complaint's allegations, and the order makes no finding that Cerebral broke the law; its findings state the court's jurisdiction and what the complaint charges. (ECF No. 6 at 2)
Defendant neither admits nor denies any of the allegations in the Complaint, except as specifically stated in the Order.
ECF No. 6 at 2
What it did not decide
- No court found that Cerebral broke any law; the judgment was entered by consent, without admission or denial of the allegations.
- The complaint pleaded no claim under the federal Wiretap Act, a state wiretap or privacy statute, or HIPAA; its counts arose under the FTC Act, the Opioid Addiction Recovery Fraud Prevention Act and the Restore Online Shoppers' Confidence Act.
- The judgment did not resolve the claims against Cerebral's former chief executive or the other defendants named in the amended complaint.
- The order's line between pre-login browsing data and health information was negotiated, so it does not decide what counts as health information under any statute.
The tracking involved
Tools
- Facebook Pixel
- Google Analytics
- Other third-party pixels and cookies
Data
- Names, email and home addresses, phone numbers and birthdates
- IP addresses and other persistent identifiers
- Mental health questionnaire answers
- Medical and prescription histories, pharmacy and health insurance information
- Treatment plans and appointment dates
- Activity on the websites and apps
How it bears on website tracking claims
Supports: strengthens a website tracking claim on this issue. Limits: narrows or defeats a website tracking claim on this issue. Context: bears on the issue without deciding it either way.
Context: Consumer protection
Deception and unfair practice claims, such as under the FTC Act and N.Y. General Business Law § 349.
The complaint charged that sharing health information through tracking tools after promising confidentiality was deceptive, and that using it for marketing without affirmative express consent was unfair (ECF No. 1 paras. 159-165, 170-173). Its theory rested on specific privacy promises, sharing that contradicted them, and disclosures placed deep in long policies (ECF No. 1 paras. 37-40, 48-52, 55). The charges were settled without findings, so the case shows how a federal regulator framed the conduct, not a ruling that it was unlawful.
Context: Consent
Whether visitors agreed to the tracking through banners, privacy policies or terms.
The order defines affirmative express consent as a freely given, specific, informed and unambiguous indication of agreement, such as a clear affirmative action, after a clear and conspicuous disclosure that is separate from any privacy policy or terms (ECF No. 6 at 3-4). It rules out consent inferred from closing or pausing content or obtained through an interface that impairs choice. The complaint also faulted an enrollment screen that linked to the terms and privacy policy without describing the information practices consumers were asked to accept (ECF No. 1 paras. 43-44). These terms bind only Cerebral, but they show the consent standard the FTC obtained in a health-data settlement.
Context: Health information
What counts as individually identifiable health information when it is sent through tracking tools.
The order treats a consumer's use of a health service, account creation and questionnaire answers as Treatment Information, and it covers persistent identifiers such as static IP addresses and user IDs (ECF No. 6 at 6-7, 13). It lets Cerebral share pages viewed before login only for analytics, advertising measurement or communications the consumer requested, and only when those pages disclose no individually identifiable health information (ECF No. 6 at 9, 14). That line between ordinary browsing and activity that reveals health information was negotiated, not decided by a court.
Context: Agency penalties and orders
Civil penalties, payments and conduct terms that regulators obtained.
The order paired a $5,087,252.89 monetary judgment with a $10 million civil penalty judgment that is suspended after a $2 million payment (ECF No. 6 at 43-45), a suspension the Commission tied to Cerebral's inability to pay (ECF No. 28 at 3). The FTC said the monetary judgment would fund partial refunds for consumers affected by the cancellation practices. The complaint sought civil penalties under the Opioid Addiction Recovery Fraud Prevention Act, which it applied to the privacy and data security practices, and under the Restore Online Shoppers' Confidence Act (ECF No. 1 paras. 178-185).
Context: HIPAA
How HIPAA, its criminal provision at 42 U.S.C. § 1320d-6 and HHS guidance bear on tracking.
The complaint alleged that Cerebral itself reported to HHS in March 2023 that its use of tracking tools was a breach of unsecured health information protected under HIPAA, affecting nearly 3.2 million consumers (ECF No. 1 para. 70). The case pleaded no HIPAA claim; that report appears only as an allegation in a complaint brought under the FTC Act and two other federal statutes.
Arguments it addresses
- The privacy policy disclosed the pixel
- The complaint called the Facebook Pixel statement, five pages into a fifteen-page policy, inconspicuous and set it against promises not to use health information for marketing without consent, and the order requires a consent disclosure separate from any privacy policy.
- Visitors agreed to the terms by clicking a button
- The complaint alleged that an enrollment button with small-print links to the terms and privacy policy did not tell consumers the specific information practices they were being asked to accept (ECF No. 1 paras. 43-44).
- The data was hashed
- The order lists hashed or salted account credentials as Covered Information and required Cerebral to identify every recipient of Covered Information in any form, including hashed or encrypted form, and to instruct each one to delete it.
- A page visit is not health information
- The order, a negotiated settlement, allows pre-login page data to be shared for analytics, measurement or requested communications only when the pages disclose no individually identifiable health information, and it treats use of a health service, account creation and questionnaire answers as Treatment Information.
- A settlement is not an admission
- Cerebral neither admitted nor denied the allegations, although it agreed that the complaint's facts would be taken as true in later litigation by or on behalf of the FTC, such as a proceeding to enforce payment (ECF No. 6 at 2, 46).
For a company that received a letter
- The Cerebral order is a negotiated settlement with the federal government that binds only Cerebral; no court ruled on whether its tracking was unlawful.
- Its definitions show what the FTC treated as sensitive for a telehealth company: persistent identifiers, account and questionnaire activity, and information inferred from them.
- The remedy required Cerebral to find every third party that received covered data, including hashed data, and to instruct each one to delete it.
- Most of the money paid was for refunds to consumers affected by the cancellation practices, and the $10 million civil penalty was suspended after a $2 million payment because of Cerebral's inability to pay, so the figures do not measure the privacy charges alone.
What to check on your own site
- Check whether any advertising pixel or tag fires on sign-up, intake questionnaire or checkout pages, and what event names and parameters it sends.
- Check whether pages viewed before login send identifiers together with page addresses that name a condition, service or treatment.
- Compare what your privacy policy and on-page statements promise about marketing use of health information with what your tags actually send.
Later history
On May 8, 2025, the FTC announced that more than $5 million in refunds was being sent to 40,249 consumers who asked to cancel on or before May 2022 but were still charged. The consent judgment resolved the case only against Cerebral, Inc. The case continued against other defendants: the operative third amended complaint, filed April 10, 2026, is against Cerebral's former chief executive and Zealthy, Inc., and on October 27, 2026, the court denied their motion to dismiss its count under the Restore Online Shoppers' Confidence Act (ECF No. 302 at 1, 29). The case was still pending on November 10, 2026.
Sources
- FTC case page
- Complaint (ECF No. 1)
- Joint stipulation for order against Cerebral, Inc. (ECF No. 6)
- First amended complaint (ECF No. 21)
- Notice of settlement as to Cerebral, Inc. (ECF No. 28)
- Court docket, including the consent judgment entry (ECF No. 33)
- FTC announcement, April 15, 2024
- FTC refund announcement, May 8, 2025
- Order denying motion to dismiss count I of the third amended complaint (ECF No. 302, October 27, 2026)
Related rulings
Published by Privacy Resolve from public records. It does not cover our own matters.
General information only, not legal advice, and not a substitute for the advice of an attorney. Laws, deadlines, defenses and outcomes vary by jurisdiction and facts.